Cases filed in Delaware
Cases 41 - 50 of 122
Bristol-Myers Squibb Company v. Lupin Limited et al
as 1:2020cv00854
Defendant: Lupin Limited, Lupin Inc. and Lupin Pharmaceuticals, Inc.
Plaintiff: Bristol-Myers Squibb Company
Cause Of Action: 35 U.S.C. § 1
Merck Sharp & Dohme Corp. v. Lupin Limited et al
as 1:2020cv00776
Defendant: Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
BIAL - PORTELA & CA. S.A. et al v. Lupin Limited et al
as 1:2020cv00782
Plaintiff: Bial - Holding, S.A., BIAL - PORTELA & CA. S.A. and Sunovion Pharmaceuticals Inc.
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al
as 1:2020cv00697
Defendant: Lupin Atlantis Holdings SA, Lupin Limited and Lupin Pharmaceuticals, Inc.
Plaintiff: Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant: Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court: Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re: Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant: Novartis Pharmaceuticals Corporation
Defendant: Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
as 1:2020cv00415
Defendant: Lupin Limited, Lupin Inc., Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. and others
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Lupin Limited et al
as 1:2020cv00293
Plaintiff: ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
CyDex Pharmaceuticals, Inc. v. Lupin Limited et al
as 1:2019cv02043
Defendant: Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff: CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Lupin Limited et al
as 1:2019cv01988
Defendant: Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al We have downloadable decisions or orders for this case
as 1:2019cv01979
Defendant: Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?